Kopin Corporation filed its Form 10-Q for the quarterly period ended September 26, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, reporting third-quarter total revenues of $18,189,872 and a net loss of $3,420,403.

Key Highlights

  • Total revenues up year-over-year: Kopin reported total revenues of $18,189,872 for the three months ended September 26, 2026, compared to $11,962,425 for the three months ended September 27, 2025, according to the filing.
  • Grant income added a new revenue line: Grant income of $3,104,650 was recorded in Q3 2026; no grant income was reported in the comparable prior-year quarter.
  • Net loss of $3,420,403 in Q3 2026: The company reported a net loss of $3,420,403 for the three months ended September 26, 2026, versus net income of $4,080,604 in the same quarter of 2025.
  • Nine-month accumulated deficit grew: The accumulated deficit stood at $405,762,820 as of September 26, 2026, compared to $399,421,251 as of December 27, 2025.
  • Cash position declined: Cash and cash equivalents were $25,845,738 at September 26, 2026, down from $36,350,083 at December 27, 2025.
  • Shares outstanding increased: Common stock outstanding was 180,618,570 shares as of September 26, 2026, up from 176,903,857 shares at December 27, 2025.
  • Accrued litigation damages unchanged: Accrued litigation damages remained at $19,700,000 on the balance sheet as of both September 26, 2026 and December 27, 2025.

Kopin's Q3 2026 Financial Results: Revenue Mix Shifts, Operating Loss Deepens

According to the filing, Kopin Corporation (NASDAQ:KOPN) reported total revenues of $18,189,872 for the three months ended September 26, 2026, a significant increase from $11,962,425 in the three months ended September 27, 2025. The filing shows the revenue mix shifted materially: net product revenues declined to $8,794,730 from $10,693,734, while research and development revenues rose to $5,684,592 from $1,199,937. Grant income of $3,104,650, which had no comparable figure in Q3 2025, contributed to the year-over-year revenue increase.

Despite the revenue gain, the company disclosed a loss from operations of $509,204 for the third quarter of 2026, compared to income from operations of $4,533,127 in Q3 2025. The filing notes that selling, general and administrative expenses increased to $6,666,963 in Q3 2026 from $1,629,175 in Q3 2025. The prior-year quarter also included a gain on legal contingency of $5,100,000, with no comparable item in Q3 2026. After non-operating items, including a loss on investments of $2,739,004, the net loss for the quarter was $3,420,403, or $0.02 per basic and diluted share.

For the nine months ended September 26, 2026, the company reported total revenues of $41,475,676 versus $30,955,800 for the same period of 2025, and a net loss of $6,341,569, compared to a net loss of $4,199,562 in the prior-year period, according to the filing. Total assets were $105,481,201 as of September 26, 2026, down from $108,394,257 at December 27, 2025. The Series A redeemable convertible preferred stock, which had 1,000 shares issued and outstanding at December 27, 2025, showed no shares issued and outstanding as of September 26, 2026, the filing disclosed.

What Was Disclosed

Kopin Corporation's Form 10-Q for the quarter ended September 26, 2026 disclosed quarterly and nine-month income statement results, a condensed consolidated balance sheet, and changes in stockholders' equity, including a growing accumulated deficit and a reduction in cash and cash equivalents relative to year-end 2025.